Daldrup & Söhne AG

  • WKN: 783057
  • ISIN: DE0007830572
  • Land: Deutschland

Nachricht vom 23.06.2021 | 09:25

Daldrup & Söhne AG receives order to sink a geothermal well for geothermal power plant in Switzerland

DGAP-News: Daldrup & Söhne AG / Key word(s): Incoming Orders
23.06.2021 / 09:25
The issuer is solely responsible for the content of this announcement.

CORPORATE NEWS

 

Daldrup & Söhne AG receives order to sink a geothermal well for geothermal power plant in Switzerland

Oberhaching / Ascheberg, 23 June 2021 - Drilling technology and geothermal specialist Daldrup & Söhne AG (ISIN DE0007830572) has been awarded a contract by a regional Swiss consortium to drill a well to develop a geothermal aquifer in the Rhone Valley. Drilling with the Drillmec "DS 20" rig with a hook load of 272 tonnes is scheduled to start in October 2021. The contract is worth a mid-single-digit million euro amount.

The well is expected to be drilled to a depth of approximately 3,000 metres. The thermal water will be used to generate electricity and heat. To this end, a consortium plans to build a geothermal power plant using ORC technology (Organic Rankine Cycle) with an electrical output of at least 4.2 GWh and a thermal output of about 15.5 GWh. Part of the heat is also to be made available to a traditional thermal spa and health resort.

About Daldrup & Söhne AG
Daldrup & Söhne AG (ISIN: DE0007830572, WKN: 783057) with a corporate history spanning more than 70 years is a specialist provider of drilling and environmental services and ranks as one of the leading companies in Germany. Its activities are divided into the business divisions Geothermics, Raw Materials & Exploration, Water Extraction as well as Environment, Development & Services (EDS). The Geothermics business division provides drilling services for near-surface geothermics (especially geothermal probes of heat pumps), along with drilling services for deep geothermics up to 6000 m, in order to utilise the geothermal energy accessible in this way for electricity and/or heat generation. In the Raw Materials and Exploration business division, the bores made by Daldrup & Söhne AG serve for exploring and developing fossil fuel deposits (especially coal and gas) as well as mineral resources and ores (e.g. copper and gold). The Water Extraction business division comprises well construction for the extraction of drinking, service, curative, mineral, boiler-feed or cooling water as well thermal brine. The Environment, Development & Services (EDS) business division comprises special environmental engineering services such as the hydraulic clean-up of contaminated sites, the drilling of gas extraction wells for recovering waste dump gas, the provision of groundwater quality measuring points or the installation of water purification plants.

The shares of Daldrup & Söhne AG are listed in the Scale (sub-segment in the open market of the Frankfurt Stock Exchange).

Disclaimer
This publication represents neither an offer for sale nor a call to submit a tender for the purchase or underwriting of securities. This publication and the information it contains is not intended for direct or indirect dissemination in or within the United States of America ("USA"), Canada, Australia or Japan.

Press & Investor Relations contact
Daldrup & Söhne AG
Falk v. Kriegsheim
Fon +49 (0)2593-9593-29
Fax +49 (0)2593-9593-60
Bajuwarenring 17a ir@daldrup.eu
82041 Oberhaching www.daldrup.eu



23.06.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Vonovia SE: Vorstandsmitglieder von Vonovia werden ihre Bezugsrechte ausüben

30. November 2021, 16:02

Aktueller Webcast

HelloFresh SE

Capital Markets Day

08. Dezember 2021

Aktuelle Research-Studie

clearvise AG

Original-Research: clearvise AG (von First Berlin Equity Research GmbH): Buy

30. November 2021